Skip to main content
TipRanks
Go Ultimate75% OFF

Basel Medical Group Ltd (BMGL) Ratios

85 Followers

Basel Medical Group Ltd Ratios

BMGL's free cash flow for Q4 2025 was S$440.98K. For the 2025 fiscal year, BMGL's free cash flow was decreased by S$-61.61K and operating cash flow was S$993.45K. See a summary of the company’s cash flow.

Financial ratios
RatiosJun 26Jun 25Jun 24Jun 23Jun 22
Liquidity Ratios
Current Ratio1.231.232.262.282.18
Quick Ratio1.211.192.252.272.17
Cash Ratio0.050.280.270.190.22
Solvency Ratio-0.03-0.910.300.240.19
Operating Cash Flow Ratio-0.06-0.410.350.400.39
Short-Term Operating Cash Flow Coverage-0.10-70.780.940.810.77
Net Current Asset ValueS$ -1.12MS$ 1.13MS$ 7.43MS$ 4.88MS$ 2.52M
Leverage Ratios
Debt-to-Assets Ratio0.540.200.260.470.60
Debt-to-Equity Ratio1.900.700.571.312.74
Debt-to-Capital Ratio0.660.410.360.570.73
Long-Term Debt-to-Capital Ratio0.400.000.170.380.59
Financial Leverage Ratio3.523.472.162.804.55
Debt Service Coverage Ratio-0.09-40.340.970.750.73
Interest Coverage Ratio18.12-10.7012.468.397.71
Debt to Market Cap1.120.000.040.060.08
Interest Debt Per Share10.512.320.240.400.56
Net Debt to EBITDA-20.67-0.040.752.052.62
Profitability Margins
Gross Profit Margin38.77%77.68%77.63%75.91%79.56%
EBIT Margin-3.67%-108.67%25.68%24.43%25.40%
EBITDA Margin-2.04%-98.24%30.94%30.17%30.80%
Operating Profit Margin38.74%-19.28%21.84%20.64%23.21%
Pretax Profit Margin-5.81%-110.47%23.92%21.97%22.39%
Net Profit Margin-3.48%-106.78%20.62%18.38%18.56%
Continuous Operations Profit Margin-6.64%-106.79%20.62%18.38%18.56%
Net Income Per EBT59.85%96.66%86.20%83.66%82.88%
EBT Per EBIT-15.00%572.85%109.54%106.42%96.45%
Return on Assets (ROA)-4.21%-71.72%12.71%11.59%11.74%
Return on Equity (ROE)-14.79%-248.66%27.41%32.49%53.38%
Return on Capital Employed (ROCE)105.14%-35.42%24.00%22.47%25.62%
Return on Invested Capital (ROIC)58.87%-25.47%15.97%13.19%14.80%
Return on Tangible Assets-4.21%-71.72%12.71%11.59%11.74%
Earnings Yield-8.67%-28.44%1.84%1.58%1.71%
Efficiency Ratios
Receivables Turnover2.084.540.810.730.77
Payables Turnover3.711.202.711.602.02
Inventory Turnover57.046.7131.2124.7031.20
Fixed Asset Turnover3.843.28173.3716.769.05
Asset Turnover1.210.670.620.630.63
Working Capital Turnover Ratio9.171.981.161.160.00
Cash Conversion Cycle83.38-168.23328.95287.52306.40
Days of Sales Outstanding175.4680.44451.91501.44475.45
Days of Inventory Outstanding6.4054.3711.6914.7811.70
Days of Payables Outstanding98.48303.04134.65228.69180.75
Operating Cycle181.86134.81463.60516.22487.15
Cash Flow Ratios
Operating Cash Flow Per Share-0.66-2.780.130.140.15
Free Cash Flow Per Share-0.92-2.810.130.140.14
Dividend Paid and CapEx Coverage Ratio-2.56-79.33316.83421.9431.56
Capital Expenditure Coverage Ratio-2.56-79.33316.83421.9431.56
Operating Cash Flow Coverage Ratio-0.07-1.270.580.360.28
Operating Cash Flow to Sales Ratio-0.03-0.380.250.270.26
Free Cash Flow Yield-10.25%-10.35%2.22%2.30%2.34%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-18.73-3.9054.4363.1358.47
Price-to-Sales (P/S) Ratio0.403.7511.2311.6010.85
Price-to-Book (P/B) Ratio1.718.7414.9220.5131.21
Price-to-Free Cash Flow (P/FCF) Ratio-9.76-9.6645.1143.4042.77
Price-to-Operating Cash Flow Ratio-13.58-9.7844.9643.3041.42
Price-to-Earnings Growth (PEG) Ratio0.200.013.47-4.660.00
Enterprise Value Multiple-40.27-3.8637.0440.5037.84
Enterprise Value17.71M42.94M115.17M118.57M124.25M
EV to EBITDA-40.27-3.8637.0440.5037.84
EV to Sales0.823.7911.4612.2211.66
EV to Free Cash Flow-20.05-9.7646.0445.7145.95
EV to Operating Cash Flow-27.88-9.8845.9045.6044.49
Tangible Book Value Per Share4.733.110.400.290.20
Shareholders’ Equity Per Share5.273.110.400.290.20
Tax and Other Ratios
Effective Tax Rate-0.140.030.140.160.17
Revenue Per Share22.437.230.540.520.57
Net Income Per Share-0.78-7.720.110.100.11
Tax Burden0.600.970.860.840.83
Interest Burden1.581.020.930.900.88
Research & Development to Revenue0.000.000.000.000.00
SG&A to Revenue0.430.580.360.340.38
Stock-Based Compensation to Revenue0.000.000.000.000.00
Income Quality0.850.351.041.221.17

Currency in SGD